Management of hyperlipidaemia
Relevant BNF section: 2.12
The concentrations of lipids in the blood correlate with the risk of developing and dying from illness associated with atheroma such as coronary heart disease (CHD). However, many other factors also affect such risk. So, while therapy that lowers lipid levels can improve outcome, this cannot necessarily be expected for all people treated. At the same time, many individuals who would probably be helped by lipid-lowering treatment do not receive it.1 Here we discuss the relationship between blood lipid concentrations and CHD, and management strategies for hyperlipidaemia, concentrating on primary and secondary prevention of CHD in adults.
This article has been cited by other articles:
-
Smellie, W S. A, Lowrie, R., Wilkinson, E.
(2001). Quality improvement report: A laboratory based intervention to improve appropriateness of lipid tests and audit cholesterol lowering in primary care. BMJ
323: 1224-1227
[Abstract] [Full Text] -
Jones, A F, Walker, J, Jewkes, C, Game, F L, Bartlett, W A, Marshall, T, Bayly, G R
(2001). Comparative accuracy of cardiovascular risk prediction methods in primary care patients. Heart
85: 37-43
[Abstract] [Full Text] -
SITUNAYAKE, R D, KITAS, G
(1997). Dyslipidaemia and rheumatoid arthritis. Ann Rheum Dis
56: 341-342
[Full Text]
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
